Fast, Simple, and Accurate PCR Testing for Urgent Care
Cepheid, a leader in molecular diagnostics, offers solutions that increase urgent care efficiency while achieving better clinical care.
GeneXpert® Family of Systems Deliver Unmatched Results from Decentralized Testing to the Point of Care
Urgent Care Clinics play a critical role in the healthcare ecosystem by providing frontline emergency care at a fraction of the cost of traditional Emergency Departments. From patients presenting respiratory distress with overlapping ILI symptoms to rapid diagnosis of sexual health diseases, this range of care needs brings unique challenges to standalone advance care clinics. Cepheid offers proven purpose-built solutions that increase your clinic efficiency while achieving higher patient satisfaction and better clinical care.
Explore the GeneXpert® system and the GeneXpert® Xpress system, as well as our extensive respiratory and sexual health test menu, to take your Urgent Care Clinic to the next level.
Seamless In-office Testing
|
|
|
|
|
|
Testing as simple as 1, 2, 3
Respiratory Solutions
Build your Urgent Care with a Single Solution for Respiratory Care
Test with the confidence of PCR using Cepheid’s GeneXpert® System and Xpress® tests. Standardized CLIA waived molecular testing for any urgent care setting — from health systems to standalone practices. Achieve accurate, actionable results when and where they are needed the most.
Multiplex PCR Testing Improves the Value of Urgent Care
Women’s and Sexual Health Solutions
Build Your Urgent Care Clinic with a Single Solution for Women's and Sexual Health Testing
Urgent Care is at the forefront of the fight against STIs. With same-day results, your practice can promote proper antibiotic stewardship and help with treatment compliance.1 Achieve accurate, actionable results when and where they are needed the most.
- For use in a CLIA-certified facility
Sexual Health Testing with the GeneXpert System during European Testing Week
Learn how a Community Testing Site in Barcelona, Spain during European Testing Week leverages same-day, point-of-care results for sexual health testing.
Sexual Health Testing with the GeneXpert System during European Testing Week
Learn how a Community Testing Site in Barcelona, Spain during European Testing Week leverages same-day, point-of-care results for sexual health testing.
Educational Materials
Respiratory Testing Brochure (Urgent Care)
Co-testing for SARS-CoV-2, flu, and RSV will be critical to detect and differentiate between disease states, enabling accurate patient diagnosis and treatment
White Paper: Leveraging Point-of-Care PCR Testing in Urgent Care
Equipping laboratories, physicians’ offices, and urgent care centers with highly accurate and rapid POC RT-PCR technology will be the way forward…
Sexual Health Testing Brochure
With same-day results, your practice can promote proper antibiotic stewardship and help with treatment compliance...
Select your area of interest
US-IVD. In Vitro Diagnostic Medical Device
Please see individual product inserts for full test run times and early assay termination times.
Please see Product inserts for individual test clearances.
*These tests have not been FDA cleared or approved. These tests have been authorized for emergency use by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
+Brackbill RM, Sternberg MR, Fishbein M. Where do people go for treatment of sexually transmitted diseases? Fam Plann Perspect 1999;31:10–5. Cross Refexternal icon Pub Medexternal icon
1Gaydos C, et al. Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management:
Report of a Randomized Clinical Trial. Ann Emerg Med. Sept 2018.